124 related articles for article (PubMed ID: 6409188)
21. A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro.
Martin PJ; Hansen JA; Vitetta ES
Blood; 1985 Oct; 66(4):908-12. PubMed ID: 3929860
[TBL] [Abstract][Full Text] [Related]
22. Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates.
Lowe JA; Ling NR; Forrester JA; Cumber AJ; Ross WC
J Immunol Methods; 1985 Jan; 76(1):93-104. PubMed ID: 3918119
[TBL] [Abstract][Full Text] [Related]
23. Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption.
Berenson RJ; Bensinger WI; Kalamasz D; Martin P
Blood; 1986 Feb; 67(2):509-15. PubMed ID: 3510682
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution of hematopoiesis after bone marrow purging with ricin A chain immunotoxin.
Fauser AA; Kanz L; Casellas P; Laurent G; Cooper BA; Löhr GW
Transplantation; 1986 Mar; 41(3):356-60. PubMed ID: 3485318
[TBL] [Abstract][Full Text] [Related]
25. Immature B cells from human and mouse bone marrow can change their surface light chain expression.
Ghia P; Gratwohl A; Signer E; Winkler TH; Melchers F; Rolink AG
Eur J Immunol; 1995 Nov; 25(11):3108-14. PubMed ID: 7489750
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
27. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
[TBL] [Abstract][Full Text] [Related]
28. Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells.
van Horssen PJ; van Oosterhout YV; Evers S; Backus HH; van Oijen MG; Bongaerts R; de Witte T; Preijers FW
Leukemia; 1999 Feb; 13(2):241-9. PubMed ID: 10025898
[TBL] [Abstract][Full Text] [Related]
29. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
Stong RC; Uckun F; Youle RJ; Kersey JH; Vallera DA
Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma.
Goldmacher VS; Bourret LA; Levine BA; Rasmussen RA; Pourshadi M; Lambert JM; Anderson KC
Blood; 1994 Nov; 84(9):3017-25. PubMed ID: 7524764
[TBL] [Abstract][Full Text] [Related]
31. Specific detection of myeloma plasma cells using anti-idiotypic single chain antibody fragments selected from a phage display library.
Willems PM; Hoet RM; Huys EL; Raats JM; Mensink EJ; Raymakers RA
Leukemia; 1998 Aug; 12(8):1295-302. PubMed ID: 9697887
[TBL] [Abstract][Full Text] [Related]
32. [Cytotoxicity of a conjugate of ricin A-chain and monoclonal anti-allotypic antibody].
Rachmanova VA; Tonevitskiĭ AG; Cherapakhin VV; Bobreneva RA
Biull Eksp Biol Med; 1988 May; 105(5):568-70. PubMed ID: 3132992
[TBL] [Abstract][Full Text] [Related]
33. Ricin B chain-containing immunotoxins prepared with heat-denatured B chain lacking galactose-binding ability potentiate the cytotoxicity of a cell-reactive ricin A chain immunotoxin.
Wawrzynczak EJ; Drake AF; Watson GJ; Thorpe PE; Vitetta ES
Biochim Biophys Acta; 1988 Aug; 971(1):55-62. PubMed ID: 2841982
[TBL] [Abstract][Full Text] [Related]
34. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.
Vitetta ES; Cushley W; Uhr JW
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6332-5. PubMed ID: 6578512
[TBL] [Abstract][Full Text] [Related]
35. Development and distribution of B lineage cells in the domestic cat: analysis with monoclonal antibodies to cat mu-, gamma-, kappa-, and lambda-chains and heterologous anti-alpha antibodies.
Klotz FW; Gathings WE; Cooper MD
J Immunol; 1985 Jan; 134(1):95-100. PubMed ID: 3917286
[TBL] [Abstract][Full Text] [Related]
36. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
Stong RC; Youle RJ; Vallera DA
Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
[TBL] [Abstract][Full Text] [Related]
37. Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains.
Pauza ME; Rehmann JA; LeBien TW
J Exp Med; 1993 Jul; 178(1):139-49. PubMed ID: 8391059
[TBL] [Abstract][Full Text] [Related]
38. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
Wu M; Tang SL; Zang RJ; Yu H
Int J Immunopharmacol; 1990; 12(2):235-9. PubMed ID: 2329015
[TBL] [Abstract][Full Text] [Related]
39. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
Preijers FW; De Witte T; Wessels JM; Meyerink JP; Haanen C; Capel PJ
Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
